Tech Company Financing Transactions
Biolinq Funding Round
Alpha Wave Ventures, Aphelion Capital and AXA Investment Managers participated in a $58 million funding round for Biolinq. The round was announced by the company on 4/4/2024.
Transaction Overview
Company Name
Announced On
4/4/2024
Transaction Type
Venture Equity
Amount
$58,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The financing will support completion of a U.S. pivotal clinical trial this year, evaluating Biolinq's proprietary intradermal glucose sensor, and subsequent FDA submission.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4535 Towne Centre Ct. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Biolinq is a digital health company developing a skin-applied, minimally-invasive electrochemical biosensor platform which analyzes biomarkers in the interstitial fluid to provide actionable health information.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jared Tangney
Chief Technical Officer
Joshua Windmiller
VP - Regulatory Affairs
Thomas Peyser
Browse more venture capital transactions:
Prev: 4/4/2024: Diagonal Therapeutics venture capital transaction
Next: 4/4/2024: Pigment venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs